IntelliCyt Corporation Announces Partnership with European Distributors
News May 25, 2011
IntelliCyt Corporation, has announced select partnerships with five prominent European distributors, delivering exclusive distribution rights for IntelliCyt's full line of instrumentation, informatics software, and assay kit products.
IntelliCyt has partnered with Bucher Biotec AG, a privately held Swiss company representing some of the most advanced U.S. and European manufacturers of highly innovative life science research products, for distribution of IntelliCyt products in Switzerland. Westburg BV, a well-respected distributor of life science and molecular diagnostic products, has secured rights for Benelux and Scandinavia.
Grupo Taper S.A., a distinguished and experienced firm, has gained distribution rights for these innovative products in Spain and Portugal. Labtech France, a leading company supporting innovative high quality products serving the life science research market, acquired rights in France.
BioTech a.s. has obtained distribution rights to the life science market in the Czech Republic, Hungary, Slovakia and Russia. IntelliCyt will continue to provide direct sales and support in North America, the United Kingdom, and Germany.
"We are delighted to have established partnerships with experienced firms that were selected due to their excellence in customer and product support, and high standards of customer focus," said Janette Phi, Senior Vice President of Business Development. "We are excited about the opportunity to serve life science researchers across Europe as well as Russia. These agreements add to IntelliCyt's growing network of leading distribution partners."
The European distributors have access to all IntelliCyt products. In addition to the HyperCyt® Sampler, the distributors have access to the newly introduced HTFC™ (high throughput flow cytometry) Screening System.
The system is a revolutionary new instrument platform designed to perform high-throughput, multiplexed, single-cell analysis on cells or particles in suspension.
The system incorporates the IntelliCyt Data Manager, an informatics platform that quickly and efficiently analyzes and manages the data from screening campaigns.
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.READ MORE